Copertina

Impact of systematic variations in hematocrit and platelet count on thrombelastometry tissue factor activated assay parameters

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Julie T. Skaugen, Mark H. Yazer, Ulrik Sprogøe
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Transfusion
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

An unusual case of reagent interference in transfusion medicine workup: Pan reactive indirect antiglobulin test caused by commercial saline solution
di: Martin Tøffner Pedersen, et al.
Pubblicazione: (2024)

Low titer group O whole blood inventory conservation: The effect of implementing group A whole blood at a simulated civilian trauma center
di: Emilie A. Jochumsen, et al.
Pubblicazione: (2026)

Trends in low titer group O whole blood use among United States trauma centers: An update from a national trauma registry from 2020 to 2024
di: Steven G. Schauer, et al.
Pubblicazione: (2026)

PF4‐dependent P‐selectin expression assay in comparison to the heparin‐induced platelet activation assay for the diagnosis of heparin‐induced thrombocytopenia
di: Romy T. Meier, et al.
Pubblicazione: (2025)

Sterility of fresh whole blood units stored for an extended period of time above room temperature
di: Grant Stapleton, et al.
Pubblicazione: (2025)

Post‐exchange neutrophil count, but not post‐hematocrit, predicts endogenous erythropoiesis in patients with sickle cell disease undergoing chronic red cell exchange
di: Nalan Yurtsever, et al.
Pubblicazione: (2024)

Effect of major trauma on the expected number of births in Finnish women: A nationwide population‐based public data and register analysis
di: Matias Vaajala, et al.
Pubblicazione: (2024)

Survey of policies at US hospitals on the selection of RhD type of low‐titer O whole blood for use in trauma resuscitation
di: Skye Clayton, et al.
Pubblicazione: (2024)

Survey of quality control testing practices on low titer group O whole blood in the United States
di: Mark H. Yazer, et al.
Pubblicazione: (2026)

Sex‐based practice patterns of low titer group O whole blood administration in pediatric trauma
di: Caitlin R. Eason, et al.
Pubblicazione: (2026)

An in silico simulation of the frequency of administering HLA‐incompatible low titer group O whole blood units when the donor pool includes unscreened female donors
di: Mark H. Yazer, et al.
Pubblicazione: (2025)

Understanding megakaryocyte phenotypes and the impact on platelet biogenesis
di: Shiyu Chen, et al.
Pubblicazione: (2024)

Impact of platelet transfusions on plasma proteomes in controlled endotoxemia and in hemato‐oncological patients
di: Eva R. Smit, et al.
Pubblicazione: (2025)

Transfusion quantities associated with 24‐h mortality in trauma patients
di: Mary L. Wallace, et al.
Pubblicazione: (2025)

Maternal–fetal platelet alloimmunization: Identification of risk factors for severe neonatal thrombocytopenia
di: Elise Deroubaix, et al.
Pubblicazione: (2026)

Correction to “Bacterial contamination rate of platelet components by primary culture: a systematic review and meta‐analysis”
Pubblicazione: (2024)

Predictive model for optimizing prehospital transfusions in an urban EMS system
di: Bo Zeng, et al.
Pubblicazione: (2025)

Improved platelet recovery in cryopreserved platelets reconstituted in freeze‐dried plasma
di: Kristina Ehn, et al.
Pubblicazione: (2026)

A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery
di: Magali J. Fontaine, et al.
Pubblicazione: (2025)

A survey of low titer O whole blood use within the trauma quality improvement program registry
di: Steven G. Schauer, et al.
Pubblicazione: (2024)

It is time to reconsider leukoreduction of whole blood for use in patients with life‐threatening hemorrhage
di: Mark H. Yazer, et al.
Pubblicazione: (2024)

Enhanced oxygen availability and preserved aggregative function in platelet concentrates stored at reduced platelet concentration
di: Jamie Nash, et al.
Pubblicazione: (2024)

A new look at an old warning: Transfusing ABO group‐specific red blood cells after large‐volume low‐titer group O whole blood in trauma resuscitation
di: Mark H. Yazer, et al.
Pubblicazione: (2025)

Clinical application of a modified platelet desialylation test for mechanistic characterization of platelet transfusion refractoriness
di: Karen Ziza, et al.
Pubblicazione: (2026)

Transfusion of cold temperature storage platelets induces rapid clearance by hepatocytes and promotes the production of platelets
di: Xian Su, et al.
Pubblicazione: (2025)

Making cold platelets even cooler: Freezing cold‐stored platelets to maximize inventory potential
di: Christopher Roan, et al.
Pubblicazione: (2025)

Anti‐D immunization after D positive platelet transfusions in D negative recipients: A systematic review and meta‐analysis
di: Tamar Hubert, et al.
Pubblicazione: (2024)

Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat
di: Meng Li, et al.
Pubblicazione: (2024)

How do we maintain a dual inventory of room temperature stored platelets with cold‐stored platelets?
di: Claudia S. Cohn, et al.
Pubblicazione: (2025)

In response: ABO nonidentical platelet transfusions and mortality
di: Neil Blumberg, et al.
Pubblicazione: (2024)

Increased platelet to red blood cell transfusion ratio associated with acute kidney injury in children with life‐threatening bleeding
di: Rachel Vaizer, et al.
Pubblicazione: (2024)

Postresuscitation platelet transfusion in major trauma patients
di: Andrea Rossetto, et al.
Pubblicazione: (2025)

An audit of platelet transfusions at a tertiary care center: New opportunities for patient blood management with the 2025 AABB / ICTMG platelet guidelines
di: Rylee Yakymi, et al.
Pubblicazione: (2026)

Strategies to improve platelet cryopreservation: A narrative review
di: Lauren Waters, et al.
Pubblicazione: (2025)

Utility of acid citrate dextrose‐acidification for platelet volume reduction protocols in the transfusion service
di: Yujung Jung, et al.
Pubblicazione: (2024)

Evolving TRALI risk across apheresis and whole blood platelet products in the United States: An 18‐year American Red Cross hemovigilance analysis
di: Pampee P. Young, et al.
Pubblicazione: (2025)

Retention of critical platelet hemostatic functions of amotosalen‐ UVA pathogen‐reduced cryoprecipitated fibrinogen complex
di: Florian Tupin, et al.
Pubblicazione: (2026)

Revisiting whole blood transfusion for the massively bleeding patient: The origins of resistance to change
di: Evan M. Bloch, et al.
Pubblicazione: (2025)

Characterization of allogeneic platelet gel from adult donor blood and umbilical cord blood activated with locally prepared cryoprecipitate and thrombin: A pilot exercise
di: Larysa Mykhailova, et al.
Pubblicazione: (2026)

Correction to “Comparable bacterial growth in platelet concentrates suspended in plasma and platelet additive solution and improved detection of bacterial contamination using a new generation automated culture system”
Pubblicazione: (2024)